Inflammasome formation in the lungs of patients with fatal COVID-19

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

(2020) Antonio Abbate et al.   CIRCULATION RESEARCH

Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies

(2020) Jennifer L. Sauter et al.   HISTOPATHOLOGY

Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19

(2020) Raphaël Cauchois et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Weathering the Cytokine Storm in COVID-19: Therapeutic Implications

(2020) Giulia Iannaccone et al.   CardioRenal Medicine

Targeting the NLRP3 Inflammasome in Severe COVID-19

(2020) Tracey L. Freeman et al.   Frontiers in Immunology

IL‐18 and infections: Is there a role for targeted therapies?

(2020) Alessandra Vecchié et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Formation of the inflammasome in acute myocarditis

(2014) Stefano Toldo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY